SCHEMBL626479

SCHEMBL626479

O=C(Nc1ncns1)C(OC1CCCC1)c1ccc(S(=O)(=O)C2CC2)nc1

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GCK P35557 19/20 0.54
KCNH2 Q12809 1/20 0.41
FFAR2 O15552 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL626817 0.99 GCK (0.54) GCKKCNH2FFAR2
SCHEMBL2660870 0.82 GCK (0.51) GCKKCNH2
SCHEMBL623717 0.80 GCK (0.59) GCK
SCHEMBL623347 0.79 GCK (0.61) GCK
SCHEMBL623640 0.77 GCK (0.48) GCK
SCHEMBL622630 0.77 GCK (0.64) GCK
SCHEMBL623516 0.76 GCK (0.47) GCK
SCHEMBL627427 0.76 GCK (0.63) GCK
SCHEMBL627263 0.75 GCK (0.51) GCKKCNH2
SCHEMBL11972043 0.74 GCK (0.59) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020357-A1 ACETAMIDE COMPOUNDS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS LTD. (IN) 2012-02-16 WO claimed
WO-2012020357-A1 ACETAMIDE COMPOUNDS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS LTD. (IN) 2012-02-16 WO disclosed